Hansen Gwenn bought NRIX
August 5, 2026 · Form 4 insider transaction
Hansen Gwenn bought 4,356 shares of Nurix Therapeutics, Inc. at $1.86 per share, a transaction worth $8.1K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Acquired (buy-side)
Shares
4,356
Price
$1.86
Total value
$8.1K
InsiderHansen Gwenn
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateAugust 5, 2026
Filing dateAugust 5, 2026
Shares owned after121,583
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.